USPTO serial 86420492
PLAN SPONSOR INSIGHT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAPTER, ALAIN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PLAN SPONSOR INSIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. McElwaine
JOHN C. MCELWAINE NELSON MULLINS RILEY & SCARBOROUGH LLP100 N TRYON STCHARLOTTE, NC 28202-4000UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Electronic publications, namely, reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; digital media and recordings, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; electronic books in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; downloadable electronic publications in the nature of reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; downloadable digital media and recordings, namely, electronic video recordings in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; Downloadable electronic data files featuring data in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; computer software for desktop publishing | ACTIVE | — |
| 016 | Printed matter, namely, books, informational sheets, journals, magazines, newspapers, newsletters, manuals, brochures, instructional and teaching materials, text books, reference books, guides, and informational leaflets in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; diaries; calendars; stationery | ACTIVE | — |
| 035 | Advertising services; business management; business administration services and managing office functions in the nature database management for others; business information management services; business consultancy services; business management and organisation consultancy services; provision of business and commercial information for the academic and scientific, and professional and business communities in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; business research services; commercial information agency services; provision of statistical information for business and commercial purposes in the field of business investments, mergers and acquisitions; conducting public opinion polling services; conducting market opinion polling studies; compilation and systemisation of information into computer databases; computerised file managing; document reproduction; arranging newspapers and magazine subscriptions for others; news clipping services; publication of publicity texts; marketing research and marketing research studies; arranging and conducting exhibitions, conferences, congresses, conventions and trade shows for business and commercial purposes; data retrieval services, namely, providing an on-line searchable database featuring business information and commercial information; business information and advisory services; research and analysis in the fields of economics; providing business information and business news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries | ACTIVE | — |
| 036 | Financial advice and consultancy services; financial research, analysis, forecasting and advisory services; financial information; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance; debt collection services; financial information evaluation, appraisal, forecasting and reporting; preparation of financial reports for others and financial analysis; financial research services; financial information and financial advisory services; financial advice and consultancy services provided online via the Internet, telecommunication and other electronic communication networks; financial research, analysis, forecasting and advisory services provided online via the Internet, telecommunication and other electronic communication networks; financial information provided online via the Internet, telecommunication and other electronic communication networks; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance provided online via the Internet, telecommunication and other electronic communication networks; debt collection services provided online via the Internet, telecommunication and other electronic communication networks; financial information evaluation, appraisal, forecasting and reporting provided online via the Internet, telecommunication and other electronic communication networks; preparation of financial reports for others and financial analysis provided online via the Internet, telecommunication and other electronic communication networks; financial research services provided online via the Internet, telecommunication and other electronic communication networks; financial information and financial advisory services provided online via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; providing financial information and financial news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries, investment strategies for high net worth individuals, and retirement planning | ACTIVE | — |
| 041 | Education services, namely, providing of training in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; arranging and conducting seminars in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; library services provided by means of a computer database which feature on-line newspapers, magazines, photographs and pictures via an on-line computer network; publication of reports, books and newsletters in the field of financial information, financial reports and financial analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mergermarket Limited
- Other trademarks owned by Mergermarket Limited
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Similar marks named PLAN SPONSOR INSIGHT
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 29, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 29, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 27, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 27, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 27, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 28, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 18, 2015 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jun 18, 2015 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 10, 2015 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 2, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 24, 2015 | ALIE | ASSIGNED TO LIE | — |
| Apr 1, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2015 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 4, 2015 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 4, 2015 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 29, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2014 | NWAP | NEW APPLICATION ENTERED | — |